4th Cytokine-Based Drug Development Summit 2023
Evvnt Promotion / evvnt
27.06.2023 - 29.06.2023 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 to 16:00
Temi della conferenza
New doors open for Cytokine drug developers to treat diseases both in and beyond oncology with novel masking and tissue targeting mechanisms and the abundance of preclinical and clinical efficacy data as more companies get additional funding to boost their pipelines.
New doors open for Cytokine drug developers to treat diseases both in and beyond oncology with novel masking and tissue targeting mechanisms and the abundance of preclinical and clinical efficacy data as more companies get additional funding to boost their pipelines.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1561164-3?pid=4832
Speakers: Alexandra Wolfarth, Senior Scientist, NeoImmuneTech Inc., Angus Sinclair, SVP Immuno-oncology Research, IGM Biosciences, and more
Brochure: https://go.evvnt.com/1561164-3?pid=4832
Speakers: Alexandra Wolfarth, Senior Scientist, NeoImmuneTech Inc., Angus Sinclair, SVP Immuno-oncology Research, IGM Biosciences, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/1561164-2?pid=4832
Mr. Hanson Wade
Oncologia
Lingua
Inglese
Inglese
Quote del Congresso
Conference Only - Drug Developer: USD 2899.00, Conference + Pre - Conference Workshop Day - Drug Developer: USD 4097.00, Conference Only - Service Provider: USD 3599.00, Conference + Pre - Conference Workshop Day - Service Provider: USD 4997.00
Conference Only - Drug Developer: USD 2899.00, Conference + Pre - Conference Workshop Day - Drug Developer: USD 4097.00, Conference Only - Service Provider: USD 3599.00, Conference + Pre - Conference Workshop Day - Service Provider: USD 4997.00
I partecipanti attesi
300 - 300
300 - 300
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
